Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Düriye Ozturk"'
Autor:
Efsun Somay, Erkan Topkan, Sibel Bascil, Nilüfer Kılıc Durankuş, Şükran Senyürek, Düriye Ozturk, Berrin Pehlivan, Ugur Selek
Publikováno v:
Biomolecules & Biomedicine (2024)
In this study, we aimed to evaluate whether the novel pretreatment Global Immune-Nutrition-Inflammation Index (GINI) can predict radiation-induced trismus (RIT) in locally advanced nasopharyngeal carcinoma (LA-NPC) patients undergoing concurrent chem
Externí odkaz:
https://doaj.org/article/e92c8105a4c94fdcbdb59b1c24949284
Autor:
Sukran Senyurek, Efsun Somay, Nilufer Kilic Durankus, Sibel Bascil, Duriye Ozturk, Ugur Selek, Erkan Topkan
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Purpose To determine the utility of the novel CARWL score, which integrates C-reactive protein-to-albumin ratio (CAR) and significant weight loss (SWL), in stratifying the locally advanced nasopharyngeal carcinoma (LA-NPC) patients into sign
Externí odkaz:
https://doaj.org/article/39069f90ff0846e39632f523df7fe233
Autor:
Efsun Somay PhD, Erkan Topkan MD, Sibel Bascil PhD, Duriye Ozturk MD, Sukran Senyurek MD, Nilufer Kilic Durankus MD, Ugur Selek MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 23 (2024)
Purpose To assess the usefulness of the novel CARWL index in predicting radiation-induced tooth loss (RITL) rates in locally advanced nasopharyngeal cancer (LA-NPC) patients undergoing concurrent chemoradiotherapy (C-CRT). Methods The study retrospec
Externí odkaz:
https://doaj.org/article/670b23e91a98407fb1c4638e252e47c7
Autor:
Erkan Topkan MD, Ugur Selek MD, Duriye Ozturk MD, Şükran Şenyürek MD, Nilüfer Kılıç Durankuş MD
Publikováno v:
Cancer Control, Vol 31 (2024)
Background To examine the prognostic relevance of pan-immune-inflammation value (PIV) in locally advanced nasopharyngeal carcinomas (LA-NPC) patients treated with concurrent chemoradiotherapy (CCRT) definitively. Methods We used receiver operating ch
Externí odkaz:
https://doaj.org/article/a8d20379255d4dc29379fd81b1964098
Autor:
Nulifer Kilic Durankus, Efsun Somay, Sibel Bascil, Sukran Senyurek, Duriye Ozturk, Ugur Selek, Erkan Topkan
Publikováno v:
Biomolecules & Biomedicine (2024)
Osteoradionecrosis (ORN) is a severe complication that can arise in patients with nasopharyngeal carcinoma due to the aggressive nature of chemoradiotherapy treatment. The purpose of our study was to assess the utility of the recently introduced CARW
Externí odkaz:
https://doaj.org/article/2a313b3d94ef4317b771da3449595076
Autor:
Erkan Topkan, Ahmet Kucuk, Emine Elif Ozkan, Duriye Ozturk, Ali Ayberk Besen, Huseyin Mertsoylu, Berrin Pehlivan, Ugur Selek
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-11 (2023)
Abstract Background and objectives We explored the prognostic usefulness of the pan-immune-inflammation value (PIV) in patients with stage IIIB/C non-small-cell lung cancer (NSCLC) who underwent concurrent chemoradiotherapy (CCRT). Methods and patien
Externí odkaz:
https://doaj.org/article/630d2705d8d24ccb9ddafca6f63a85f8
Autor:
Efsun Somay, Busra Yilmaz, Erkan Topkan, Beyza Sirin Ozdemir, Duriye Ozturk, Ali Ayberk Besen, Huseyin Mertsoylu, Ugur Selek
Publikováno v:
International Journal of Surgical Oncology, Vol 2024 (2024)
Purpose. To evaluate the predictive potency of a novel index combining the pan-immune-inflammatory index and hemoglobin levels (PIV/Hb) for the prevalence of radiation-induced trismus (RIT) in patients with locally advanced nasopharyngeal cancer (LA-
Externí odkaz:
https://doaj.org/article/6c2d3c99b4444ab0809e24012b8e8406
Autor:
Erkan Topkan, Ahmet Kucuk, Duriye Ozturk, Emine Elif Ozkan, Ali Ayberk Besen, Berrin Pehlivan, Ugur Selek
Publikováno v:
Canadian Respiratory Journal, Vol 2024 (2024)
Objectives. We explored the prognostic utility of the unique combination of C-reactive-protein-to-albumin ratio (CAR) and significant weight loss (WL > 5%) over the preceding 6 months, namely, the CARWL score, in stage IIIC non-small-cell lung cancer
Externí odkaz:
https://doaj.org/article/6c4451085660434d940b3c7e80cbf9ad